| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_KLHL2_0002000 | Intron-Exon-Intron | chr4:166141086-166198695 | chr4:165219934-165277543 | 126 nt | 0.4048 |
| hsa_KLHL2_0002100 | Exon-Exon | chr4:166141086-166220808 | chr4:165219934-165299656 | 150 nt | 0.4667 |
| hsa_KLHL2_0002400 | Exon-Exon | chr4:166149959-166160051 | chr4:165228807-165238899 | 229 nt | 0.4236 |
| hsa_KLHL2_0002600 | Exon-Exon | chr4:166149959-166184511 | chr4:165228807-165263359 | 270 nt | 0.4593 |
| hsa_KLHL2_0002500 | Exon-Exon | chr4:166149959-166220808 | chr4:165228807-165299656 | 769 nt | 0.4382 |
| hsa_KLHL2_0002800 | Intron-Exon-Intron | chr4:166159930-166161616 | chr4:165238778-165240464 | 1687 nt | 0.3651 |
| hsa_KLHL2_0002900 | Exon-Exon | chr4:166159930-166226877 | chr4:165238778-165305725 | 780 nt | 0.4526 |
| hsa_KLHL2_0003000 | Intron-Intron | chr4:166170109-166171534 | chr4:165248957-165250382 | 1426 nt | 0.4257 |
| hsa_chr4_0257200 | Intergenic-Intergenic | chr4:166174167-166175541 | chr4:165253015-165254389 | 1375 nt | 0.3796 |
| hsa_chr4_0257300 | Intergenic-Intergenic | chr4:166176897-166177057 | chr4:165255745-165255905 | 161 nt | 0.4286 |
A study in humans identified the circKLHL2 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically characterized [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in mice and human patients demonstrated that the circKLHL2 may expedite sepsis-induced acute lung injury by adjusting the miR-29b-3p/ROCK axis [Xu et al. DOI:10.1080/01902148.2024.2429184].